| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/10/2008 | CN101317817A External slimming coating agent |
| 12/10/2008 | CN101317727A Pillow with health care function |
| 12/10/2008 | CN101317666A High-efficiency composite food cellulose and preparation method thereof |
| 12/10/2008 | CN101317660A Method for improving soly solubility of monascus lovastatin in water and application thereof |
| 12/10/2008 | CN101317650A Edible mushroom foods and preparing method thereof |
| 12/10/2008 | CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 12/10/2008 | CN100441581C 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 12/10/2008 | CN100441570C Preparation of mitiglinide calcium and its quality control method |
| 12/10/2008 | CN100441197C Medicinal composition containing panax ginseng polysaccharide |
| 12/10/2008 | CN100441186C Medical use of artificial lywrine |
| 12/10/2008 | CN100441184C Method of treating atherosclerosis, dyslipidemias and related conditions and medical composition |
| 12/10/2008 | CN100441181C Method for preparing micropill capsule of salvia miltiorrhiza bge, and gynostemma pentaphyllum, and its use |
| 12/10/2008 | CN100441180C Use of sulfonamide derivatives as ligands for 5-ht6, in treatment of e.g. food ingestion disorder, obesity, bulimia, anorexia, cachexia and type ii diabetes |
| 12/10/2008 | CN100441110C Health article for regulating blood serum HDL-C concentration and treating hyperlipemia |
| 12/09/2008 | US7462733 Preparation and use of α-keto phosphonates |
| 12/09/2008 | US7462716 Statin derivatives |
| 12/09/2008 | US7462640 e.g. 5-Chloro-3-methyl-N-[1-[2-(pyrrolidin-1-yl)ethyl-1H-indol-6-yl]-benzo[b]thiophene-2-sulfonamide; serotonin receptor modulator; anxiolytic agent, antidepressant; nervous and gastrointestinal disorders, antidiabetic agent; bipolar disorders, cognitive memory disorders, neurodegenerative disorders |
| 12/09/2008 | US7462635 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia |
| 12/09/2008 | US7462626 Compositions for affecting weight loss |
| 12/09/2008 | US7462621 9-[3-(2-Fluorophenyl)-propyl]-7,7-dimethyl-2-(pyridin-4-yl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; neurodegenerative disease caused by abnormal activity of GSK3 beta (glycogen synthase kinase beta 3) or GSK3 beta and cdk5/p253 |
| 12/09/2008 | US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 12/09/2008 | US7462616 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 12/09/2008 | US7462592 Compositions and methods for polynucleotide delivery |
| 12/09/2008 | US7462370 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals |
| 12/09/2008 | US7462368 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate |
| 12/09/2008 | US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis |
| 12/09/2008 | CA2405553C Bone-strengthening agent, bone-strengthening food and bone-strengthening feed composition |
| 12/09/2008 | CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/09/2008 | CA2286913C Composition and methods using an eutomer |
| 12/04/2008 | WO2008148064A1 Weight loss treatment |
| 12/04/2008 | WO2008147826A1 Malaria liver stage drugs |
| 12/04/2008 | WO2008147807A2 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal |
| 12/04/2008 | WO2008147417A1 Method of treating diabetes |
| 12/04/2008 | WO2008146955A1 Compositions for suppressing obesity |
| 12/04/2008 | WO2008146914A1 Heterocyclic compound |
| 12/04/2008 | WO2008146907A1 Oral composition |
| 12/04/2008 | WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
| 12/04/2008 | WO2008146835A1 Composition for promoting equol production in the blood of subject unable to produce equol |
| 12/04/2008 | WO2008146732A1 Infusion solution for peripheral intravenous administration |
| 12/04/2008 | WO2008146731A1 Method for preparation of infusion solution for peripheral intravenous administration |
| 12/04/2008 | WO2008146050A1 Medicinal-preventive nutrient combination and foodstuffs on the basis thereof |
| 12/04/2008 | WO2008145524A2 4,4-disubstituted piperidine derivatives |
| 12/04/2008 | WO2008145375A2 Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development |
| 12/04/2008 | WO2008145135A1 Antidepressiva for treatment of metabolic syndrome |
| 12/04/2008 | WO2008145064A1 The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof |
| 12/04/2008 | WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
| 12/04/2008 | WO2008144880A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| 12/04/2008 | WO2008125901A3 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof |
| 12/04/2008 | WO2008099423A3 A novel herbal drug and a process for preparation thereof for the prevention and management of endothellal dysfunction among type-ii diabetes mellitus cases |
| 12/04/2008 | WO2008080042A3 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles |
| 12/04/2008 | WO2008067863A3 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 12/04/2008 | WO2008062905A3 Heteromonocyclic compound and use thereof |
| 12/04/2008 | WO2008055801A3 Antidiabetogenic calcium-peptide composition |
| 12/04/2008 | WO2008022974A3 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 12/04/2008 | WO2008008517A3 Bridged diazepan orexin receptor antagonists |
| 12/04/2008 | US20080300308 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses |
| 12/04/2008 | US20080300306 Novel Compounds |
| 12/04/2008 | US20080300293 Combination of an dpp-iv inhibitor and a ppar-alpha compound |
| 12/04/2008 | US20080300290 Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments |
| 12/04/2008 | US20080300289 (R,S)-5-[1-(4'-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-2-methyl-propyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide, used for the treatment of metabolic disorders, such as diabetes, non-insulin dependent diabetes and hyperglycemia |
| 12/04/2008 | US20080300286 Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma |
| 12/04/2008 | US20080300284 sustained release niacin formulation with side effect reduction of liver toxicity and effects on glucose metabolism and uric acid levels |
| 12/04/2008 | US20080300282 Coupling thiazolidine-2,4-dione with p-(2-alkylpyridyl-2-hydroxy-, Cl-, Br-, mesyl- or tosyl-ethoxybenzaldehyde in a solvent, an organic base and an organic acid catalyst and hydrogenating the product to form 5-[4-[2-(alkylpyridyl)2-hydroxy-, Cl-, Br-, mesyl- or tosylethoxy]benzyl-2,4-thiazolidinedione |
| 12/04/2008 | US20080300278 central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents; cardiovascular disorders |
| 12/04/2008 | US20080300256 vanilloid receptor antagonists such as 2-({2-[butyl-(3-chlorobenzoyl)-amino]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine-3-carbonyl}-amino)-3-methyl-benzyl butyrate, used as analgesics |
| 12/04/2008 | US20080300251 Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors |
| 12/04/2008 | US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 12/04/2008 | US20080300232 N-Piperidine Derivatives as Ccr3 Modulators |
| 12/04/2008 | US20080300223 (20R)-2a-Methyl-19,26,27-Trinor-Vitamin D Analogs |
| 12/04/2008 | US20080300220 Linkable Lewis X Analogs |
| 12/04/2008 | US20080300195 Metabolic imprinting |
| 12/04/2008 | US20080300190 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating |
| 12/04/2008 | US20080300180 Growth Hormone Secretagogue Receptor 1A Ligands |
| 12/04/2008 | US20080300173 Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
| 12/04/2008 | US20080300172 Method and Compositions for the Treatment of Diabetes and Related Complications |
| 12/04/2008 | US20080300171 Use of Dpp-IV Inhibitor to Reduce Hypoglycemic Events |
| 12/04/2008 | US20080300170 Compositions and methods for diagnosis and treatment for type 2 diabetes |
| 12/04/2008 | US20080299239 Inhibitor of Glucose Absorption and Method for Producing the Same |
| 12/04/2008 | US20080299236 The present invention refers to a new composition comprising natural herbs for the treatment of diabetes, and to a method for preparing said composition. |
| 12/04/2008 | US20080299196 Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester |
| 12/04/2008 | US20080299146 Satiating dietetic product |
| 12/04/2008 | US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof |
| 12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
| 12/04/2008 | US20080299129 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 12/04/2008 | US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof |
| 12/04/2008 | US20080299088 Uses of Notch Receptors, Notch Ligands, and Notch Modulators in Methods Related to Metabolic Diseases |
| 12/04/2008 | US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene |
| 12/04/2008 | CA2689957A1 Metabolic imprinting |
| 12/04/2008 | CA2688570A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof |
| 12/04/2008 | CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome |
| 12/04/2008 | CA2688293A1 Dietary formulations and methods for treatment of inflammation and other disorders |
| 12/04/2008 | CA2688111A1 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal |
| 12/04/2008 | CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity |
| 12/04/2008 | CA2687381A1 Method of treating diabetes |
| 12/04/2008 | CA2687365A1 4,4-disubstituted piperidine derivatives |
| 12/03/2008 | EP1997829A1 Albumin fusion proteins |
| 12/03/2008 | EP1997533A1 Heterocyclic boronic acid compounds, dipeptidyl peptidase IV inhibitors |
| 12/03/2008 | EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/03/2008 | EP1997489A1 Adamantylglycine derivatives as inhibitors of dipeptidyl peptidase IV for the treatment of diabetes |
| 12/03/2008 | EP1997484A2 Method of identifying GLP-1 secretagogues |